4th Edition of World Congress on Infectious Diseases
June 21-22, 2023 | Rome, Italy
Viruses and Cancer
A virus is a parasitic organism that cannot replicate on its own. A virus, on the other hand, can command the cell machinery to make new viruses once it has infected a susceptible cell. The genetic substance of most viruses is either RNA or DNA. Single-stranded or double-stranded nucleic acids are both possible. The nucleic acid and a protein outer shell make up the entire infectious virus particle, known as a virion. Only enough RNA or DNA is present in the smallest viruses to encode four proteins. The most complicated genes can encode between 100 and 200 proteins. Infectious pathogens are responsible for around a fifth of all human malignancies globally. Seven distinct viruses have been causally related to human oncogenesis in 12% of cancers.
- Oncolytic Viruses
- Oncogenic Viruses and Cancer
- Cancer Immunotherapy
Ranjan Ramasamy
IDFISH Technology, United States
Stephen Hsu
Augusta University, United States
Alfonso Recordare
Dell'Angelo Hospital, Italy
Brandon Lucke-Wold
Baylor University, United States
Walter Fabricio Silva Martins
Liverpool School of Tropical Medicine, United Kingdom
Jaime David Acosta Espana
University of Jena, Germany
Rickyle Christopher Balea
The University of the Sunshine Coast, AustraliaSubmit your abstract Today
Title : MVA-based virotherapies in the treatment of infectious diseases
Genevieve Inchauspe, ImmunResQ Department, France
Title : Phage therapy in clinical practice: Experience in chronic bone infections
Alfonso Recordare, Dell'Angelo Hospital, Italy
Title : Essential functions of RNA virus genome beyond the storage of protein-coding information
Alfredo Berzal-Herranz, Instituto de Parasitologia y Biomedicina “Lopez-Neyra”, (IPBLN) CSIC, Spain
Title : The rationale of ethanol inhalation for disinfection of the respiratory tract in SARS-CoV-2-positive asymptomatic subjects
Pietro Salvatori, Private Practice, Italy
Title : Rapid, isothermal detection of Zika virus: a potential alternative to RT-PCR
Rickyle Christopher Balea, The University of the Sunshine Coast, Australia
Title : Comparisons of the molnupiravir, sotrovimab, and remdesivir use for COVID-19 patients in a tertiary hospital of Japan
Seki Masafumi, Saitama Medical University International Medical Center, Japan